HK1052645B - 柔軟組織及擴大骨骼及擴大使用得自肌肉的祖先細胞,其組成及治療 - Google Patents
柔軟組織及擴大骨骼及擴大使用得自肌肉的祖先細胞,其組成及治療Info
- Publication number
- HK1052645B HK1052645B HK03104760.7A HK03104760A HK1052645B HK 1052645 B HK1052645 B HK 1052645B HK 03104760 A HK03104760 A HK 03104760A HK 1052645 B HK1052645 B HK 1052645B
- Authority
- HK
- Hong Kong
- Prior art keywords
- mdcs
- soft tissue
- bulking
- compositions
- muscle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
- C12N5/0659—Satellite cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/549,937 US7115417B1 (en) | 1998-05-01 | 2000-04-14 | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof |
PCT/US2001/012084 WO2001078754A2 (en) | 2000-04-14 | 2001-04-12 | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1052645A1 HK1052645A1 (en) | 2003-09-26 |
HK1052645B true HK1052645B (zh) | 2008-03-20 |
Family
ID=24195003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03104760.7A HK1052645B (zh) | 2000-04-14 | 2003-07-04 | 柔軟組織及擴大骨骼及擴大使用得自肌肉的祖先細胞,其組成及治療 |
Country Status (13)
Country | Link |
---|---|
US (3) | US9499791B2 (zh) |
EP (1) | EP1272204B1 (zh) |
JP (2) | JP5684963B2 (zh) |
AT (1) | ATE365045T1 (zh) |
AU (2) | AU5159901A (zh) |
CA (1) | CA2406393C (zh) |
CY (1) | CY1108090T1 (zh) |
DE (1) | DE60129007T2 (zh) |
DK (1) | DK1272204T3 (zh) |
ES (1) | ES2288946T3 (zh) |
HK (1) | HK1052645B (zh) |
PT (1) | PT1272204E (zh) |
WO (1) | WO2001078754A2 (zh) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6485723B1 (en) | 1995-02-10 | 2002-11-26 | Purdue Research Foundation | Enhanced submucosal tissue graft constructs |
US8211423B2 (en) * | 2006-11-28 | 2012-07-03 | University Of Pittsburgh | Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same |
US6866842B1 (en) | 1998-05-01 | 2005-03-15 | University Of Pittsburgh | Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction |
US7115417B1 (en) | 1998-05-01 | 2006-10-03 | Chancellor Michael B | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof |
PT1272204E (pt) | 2000-04-14 | 2007-10-02 | Univ Pittsburgh | Aumento e enchimento de tecidos moles e osso utilizando células progenitoras derivadas de músculo, suas composições e tratamentos |
WO2002067867A2 (en) | 2001-02-23 | 2002-09-06 | The University Of Pittsburgh | Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
US20030082153A1 (en) * | 2001-10-22 | 2003-05-01 | The Government Of The United States Of America | Stem cells that transform to beating cardiomyocytes |
AU2003231248B2 (en) | 2002-05-02 | 2009-03-05 | Purdue Research Foundation | Vascularization enhanced graft constructs |
CA2484614A1 (en) | 2002-05-02 | 2003-11-13 | Cook Biotech Incorporated | Cell-seeded extracellular matrix grafts |
JP2005524699A (ja) | 2002-05-02 | 2005-08-18 | パーデュー・リサーチ・ファウンデーション | 血管新生が促進された移植片構成物 |
EP1503789A4 (en) | 2002-05-02 | 2006-08-02 | Purdue Research Foundation | IMPROVED VASCULARIZATION BY GRAFT CONSTRUCTIONS |
JP4764626B2 (ja) | 2002-05-06 | 2011-09-07 | ベクトン・ディキンソン・アンド・カンパニー | 薬剤の薬物動力学を制御する方法およびデバイス |
CN100482228C (zh) * | 2002-08-23 | 2009-04-29 | 彼得·K·罗 | 生物的皮肤修复和增强 |
CN1812800B (zh) | 2003-04-25 | 2013-01-16 | 匹兹堡大学 | 用于促进和增强神经修复和再生的肌肉来源的细胞(mdc) |
WO2005046746A2 (en) | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
WO2005070439A1 (en) * | 2004-01-09 | 2005-08-04 | Regeneration Technologies Inc. | Implant comprising a human muscle tissue matrix |
WO2005070328A1 (en) | 2004-01-09 | 2005-08-04 | Regeneration Technologies, Inc. | Muscle-based grafts/implants |
US7001430B2 (en) | 2004-01-09 | 2006-02-21 | Regeneration Technologies, Inc. | Matrix composition for human grafts/implants |
CA2607975A1 (en) * | 2005-05-30 | 2006-12-07 | Commonwealth Scientific And Industrial Research Organisation | Preparation and use of basement membrane particles |
US20070065415A1 (en) * | 2005-09-16 | 2007-03-22 | Kleinsek Donald A | Compositions and methods for the augmentation and repair of defects in tissue |
US7815923B2 (en) | 2005-12-29 | 2010-10-19 | Cook Biotech Incorporated | Implantable graft material |
US20100158875A1 (en) | 2006-12-18 | 2010-06-24 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same |
JP5570814B2 (ja) * | 2006-12-18 | 2014-08-13 | ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | 胃食道病理学を処置するための筋由来細胞ならびにその作成法および使用法 |
EP2118271B1 (en) | 2007-01-11 | 2018-04-18 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same |
ATE554160T1 (de) * | 2007-05-29 | 2012-05-15 | Univ Pittsburgh | Knochenaufbau anhand von vorläuferzusammensetzungen aus muskeln und behandlungen damit |
CA2701354C (en) * | 2007-10-04 | 2018-07-24 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Skeletal muscle augmentation utilizing muscle-derived progenitor compositions, and treatments thereof |
AU2009282619B2 (en) | 2008-08-18 | 2015-08-20 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof |
US20130123647A1 (en) | 2011-05-03 | 2013-05-16 | The Research Foundation Of State University Of New York | Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections |
US9878071B2 (en) | 2013-10-16 | 2018-01-30 | Purdue Research Foundation | Collagen compositions and methods of use |
WO2016172365A1 (en) | 2015-04-21 | 2016-10-27 | Purdue Research Foundation Office Of Technology Commercialization | Cell-collagen-silica composites and methods of making and using the same |
EP3615568A4 (en) | 2017-04-25 | 2021-01-20 | Purdue Research Foundation | TISSUE RESTORATION THREE-DIMENSIONAL (3D) ARTIFICIAL MUSCLE |
EP4223872A3 (en) | 2017-12-14 | 2023-08-23 | Innovacell AG | Methods for obtaining muscle derived cells |
EP3942020B1 (en) | 2019-03-22 | 2024-05-15 | Innovacell GmbH | Methods for obtaining induced smooth muscle cells |
EP3778875A1 (en) * | 2019-08-14 | 2021-02-17 | MaxiVax SA | Immortalized myoblast cell lines and uses thereof |
WO2024047234A1 (en) | 2022-09-02 | 2024-03-07 | Universität Zürich | Injection device |
WO2024110320A1 (en) | 2022-11-21 | 2024-05-30 | ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE | System for control of spasticity |
WO2024115761A1 (en) | 2022-12-01 | 2024-06-06 | Universität Zürich | Method of preparing a mass culture of muscle precursor cells (mpcs) and uses thereof |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4424208A (en) | 1982-01-11 | 1984-01-03 | Collagen Corporation | Collagen implant material and method for augmenting soft tissue |
US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
US5266480A (en) | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US5902741A (en) | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
US5863531A (en) | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5510254A (en) | 1986-04-18 | 1996-04-23 | Advanced Tissue Sciences, Inc. | Three dimensional cell and tissue culture system |
US5053050A (en) | 1988-04-29 | 1991-10-01 | Samuel Itay | Compositions for repair of cartilage and bone |
US5130141A (en) * | 1988-05-24 | 1992-07-14 | Law Peter K | Compositions for and methods of treating muscle degeneration and weakness |
US5082670A (en) | 1988-12-15 | 1992-01-21 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system |
US5045601A (en) | 1989-06-13 | 1991-09-03 | Biointerface Technologies, Inc. | Pressure-sensitive adhesive compositions suitable for medical uses |
US5538722A (en) | 1989-06-13 | 1996-07-23 | Stanford University | Isolation, growth, differentiation and genetic engineering of human muscle cells |
CA2045630A1 (en) | 1989-11-24 | 1991-05-25 | Lawrence Austin | Proliferative action of leukaemia inhibitory factor on satellite cells |
US5206028A (en) | 1991-02-11 | 1993-04-27 | Li Shu Tung | Dense collagen membrane matrices for medical uses |
US6497872B1 (en) | 1991-07-08 | 2002-12-24 | Neurospheres Holdings Ltd. | Neural transplantation using proliferated multipotent neural stem cells and their progeny |
CA2133756C (en) | 1992-04-06 | 2000-02-22 | Robert A. Ersek | Treatment of urological and gastric fluid reflux disorders by injection of micro particles |
AU687359B2 (en) | 1992-09-28 | 1998-02-26 | Brown University Research Foundation | Chitosan matrices for encapsulated cells |
WO1994021299A1 (en) | 1993-03-19 | 1994-09-29 | Medinvent | A composition and a method for tissue augmentation |
US5709854A (en) | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US6001654A (en) | 1994-01-28 | 1999-12-14 | California Institute Of Technology | Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors |
US5656478A (en) | 1994-02-25 | 1997-08-12 | The Regents Of The University Of California | Smooth muscle tissue formation in vivo using cultured smooth muscle cells combined with an extracellular matrix |
US6174333B1 (en) | 1994-06-06 | 2001-01-16 | Osiris Therapeutics, Inc. | Biomatrix for soft tissue regeneration using mesenchymal stem cells |
US5516532A (en) | 1994-08-05 | 1996-05-14 | Children's Medical Center Corporation | Injectable non-immunogenic cartilage and bone preparation |
US5594032A (en) | 1994-11-10 | 1997-01-14 | Gonzalez-Cadavid; Nestor F. | Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA |
SG74036A1 (en) | 1994-12-13 | 2000-07-18 | Peter K Law | Instrument for cell culture |
US7141072B2 (en) | 1998-10-05 | 2006-11-28 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method for promoting regeneration of surface cartilage in a damaged joint using multi-layer covering |
US5833978A (en) | 1995-03-16 | 1998-11-10 | Universite Laval | Method of in vitro preconditioning healthy donor's myoblasts before transplantation thereof in compatible patients suffering of recessive myopathies like muscular dystrophy, for improving transplantation success |
US5733337A (en) | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US6121042A (en) | 1995-04-27 | 2000-09-19 | Advanced Tissue Sciences, Inc. | Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs |
US5855610A (en) | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
AU706026B2 (en) * | 1995-06-06 | 1999-06-10 | Case Western Reserve University | Myogenic differentiation of human mesenchymal stem cells |
US5591444A (en) | 1995-07-28 | 1997-01-07 | Isolagen Technologies, Inc. | Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
US5869041A (en) | 1996-01-12 | 1999-02-09 | The Miriam Hospital | Delivery of bioactive compounds to an organism |
US6200606B1 (en) | 1996-01-16 | 2001-03-13 | Depuy Orthopaedics, Inc. | Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
US5858351A (en) | 1996-01-18 | 1999-01-12 | Avigen, Inc. | Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors |
US5876447A (en) | 1996-02-14 | 1999-03-02 | Implantech Associates | Silicone implant for facial plastic surgery |
US5842477A (en) | 1996-02-21 | 1998-12-01 | Advanced Tissue Sciences, Inc. | Method for repairing cartilage |
US6299905B1 (en) | 1996-04-16 | 2001-10-09 | Depuy Orthopaedics, Inc. | Bioerodable polymeric adhesives for tissue repair |
US5895745A (en) * | 1996-09-25 | 1999-04-20 | W.R. Grace & Co.-Conn. | Method of thawing cryopreserved cells |
US6150338A (en) | 1997-02-13 | 2000-11-21 | Albert Einstein College Of Medicine Of Yeshiva University | Gene therapy for alleviating erectile dysfunction |
CA2285709A1 (en) | 1997-04-01 | 1998-10-08 | The General Hospital Corporation | Molecular marker for muscle stem cells |
US6099832A (en) | 1997-05-28 | 2000-08-08 | Genzyme Corporation | Transplants for myocardial scars |
US6110459A (en) | 1997-05-28 | 2000-08-29 | Mickle; Donald A. G. | Transplants for myocardial scars and methods and cellular preparations |
US20020068048A1 (en) | 1997-09-05 | 2002-06-06 | Patrick A. Dreyfus | Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
US6171340B1 (en) | 1998-02-27 | 2001-01-09 | Mcdowell Charles L. | Method and device for regenerating cartilage in articulating joints |
DE69922352T2 (de) | 1998-03-06 | 2005-12-15 | Biosphere Medical, Inc., Rockland | Implantierbare partikel zur erhöhung des gewebevolumens und zur behandlung von gastroösophagalreflux, inkontinenz und hautfalten |
EP1062321B1 (en) * | 1998-03-13 | 2004-12-29 | Osiris Therapeutics, Inc. | Uses for humane non-autologous mesenchymal stem cells |
DK1066052T3 (da) | 1998-03-18 | 2006-06-12 | Osiris Therapeutics Inc | Mesenchymstamceller til forebyggelse og behandling af immunreaktioner ved transplantationer |
US6866842B1 (en) | 1998-05-01 | 2005-03-15 | University Of Pittsburgh | Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction |
US7115417B1 (en) | 1998-05-01 | 2006-10-03 | Chancellor Michael B | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof |
US8211423B2 (en) | 2006-11-28 | 2012-07-03 | University Of Pittsburgh | Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same |
DE69939956D1 (de) | 1998-05-01 | 2009-01-02 | Univ Pittsburgh | Verwendung von Myoblasten zur Herstellung eines Medikaments zur Behandlung der stressbedingten Harninkontinenz |
WO1999056786A1 (de) | 1998-05-05 | 1999-11-11 | Institut für Diagnostikforschung GmbH an der Freien Universität Berlin | Diagnostisches mittel 2 oder 3 komponenten für die mr-diagnostik |
EP1083828B1 (en) | 1998-06-05 | 2009-03-04 | Organogenesis Inc. | Bioengineered vascular graft prostheses |
US6190893B1 (en) | 1998-09-18 | 2001-02-20 | Massachusetts Institute Of Technology | Electroactive materials for stimulation of biological activity of bone marrow stromal cells |
WO2000029552A1 (en) | 1998-11-16 | 2000-05-25 | Osiris Therapeutics, Inc. | Alginate layer system for chondrogenic differentiation of human mesenchymal stem cells |
JP2000287683A (ja) | 1999-04-08 | 2000-10-17 | Frontier:Kk | ニューロン生存活性を有する筋由来成分およびrna |
US6328762B1 (en) | 1999-04-27 | 2001-12-11 | Sulzer Biologics, Inc. | Prosthetic grafts |
US6306424B1 (en) | 1999-06-30 | 2001-10-23 | Ethicon, Inc. | Foam composite for the repair or regeneration of tissue |
WO2001019966A2 (en) | 1999-09-14 | 2001-03-22 | Children's Medical Center Corporation, The | Isolation of muscle-derived stem cells and uses therefor |
US7427284B2 (en) | 1999-12-03 | 2008-09-23 | University Of Leeds | Fixation technology |
US6368859B1 (en) | 1999-12-29 | 2002-04-09 | Children's Medical Center Corporation | Methods and compositions for producing a fascial sling |
AU2006202380B2 (en) | 2000-04-14 | 2007-06-21 | University Of Pittsburgh | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
PT1272204E (pt) | 2000-04-14 | 2007-10-02 | Univ Pittsburgh | Aumento e enchimento de tecidos moles e osso utilizando células progenitoras derivadas de músculo, suas composições e tratamentos |
US6682761B2 (en) | 2000-04-20 | 2004-01-27 | Rtp Pharma, Inc. | Water-insoluble drug particle process |
FR2810045B1 (fr) | 2000-06-07 | 2004-09-03 | Assist Publ Hopitaux De Paris | Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations |
CA2430554A1 (en) | 2000-12-01 | 2002-07-25 | Nephros Therapeutics, Inc. | Intravascular blood conditioning device and use thereof |
WO2002067867A2 (en) | 2001-02-23 | 2002-09-06 | The University Of Pittsburgh | Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
CA2338124C (en) | 2001-02-26 | 2010-08-03 | Valerie Dumont Dicianna | Self-tanning composition in sheeted substrate |
KR100694963B1 (ko) | 2001-04-13 | 2007-03-14 | (주)안트로젠 | 이식용 세포의 생산방법 |
EP1539934A2 (en) | 2002-07-30 | 2005-06-15 | Tigenix N.V. | Compositions comprising muscle progenitor cells and uses thereof |
CN1812800B (zh) | 2003-04-25 | 2013-01-16 | 匹兹堡大学 | 用于促进和增强神经修复和再生的肌肉来源的细胞(mdc) |
CN101040042B (zh) | 2004-08-16 | 2013-06-19 | 细胞研究私人有限公司 | 自脐带羊膜分离干/祖细胞 |
WO2007003961A2 (en) | 2005-06-30 | 2007-01-11 | Prosidion Limited | Gpcr agonists |
JP5570814B2 (ja) | 2006-12-18 | 2014-08-13 | ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | 胃食道病理学を処置するための筋由来細胞ならびにその作成法および使用法 |
EP2118271B1 (en) | 2007-01-11 | 2018-04-18 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same |
TW200902007A (en) | 2007-05-25 | 2009-01-16 | Astrazeneca Ab | Spirocyclopropyl piperidine derivatives |
ATE554160T1 (de) | 2007-05-29 | 2012-05-15 | Univ Pittsburgh | Knochenaufbau anhand von vorläuferzusammensetzungen aus muskeln und behandlungen damit |
AU2009282619B2 (en) | 2008-08-18 | 2015-08-20 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof |
-
2001
- 2001-04-12 PT PT01924998T patent/PT1272204E/pt unknown
- 2001-04-12 JP JP2001576054A patent/JP5684963B2/ja not_active Expired - Lifetime
- 2001-04-12 DE DE60129007T patent/DE60129007T2/de not_active Expired - Lifetime
- 2001-04-12 ES ES01924998T patent/ES2288946T3/es not_active Expired - Lifetime
- 2001-04-12 AU AU5159901A patent/AU5159901A/xx active Pending
- 2001-04-12 CA CA2406393A patent/CA2406393C/en not_active Expired - Lifetime
- 2001-04-12 AU AU2001251599A patent/AU2001251599B2/en not_active Expired
- 2001-04-12 DK DK01924998T patent/DK1272204T3/da active
- 2001-04-12 AT AT01924998T patent/ATE365045T1/de active
- 2001-04-12 EP EP01924998A patent/EP1272204B1/en not_active Revoked
- 2001-04-12 WO PCT/US2001/012084 patent/WO2001078754A2/en active IP Right Grant
-
2003
- 2003-07-04 HK HK03104760.7A patent/HK1052645B/zh not_active IP Right Cessation
-
2007
- 2007-06-28 CY CY20071100849T patent/CY1108090T1/el unknown
-
2008
- 2008-10-03 US US12/245,379 patent/US9499791B2/en active Active
-
2012
- 2012-04-19 JP JP2012095437A patent/JP2012180355A/ja not_active Withdrawn
-
2016
- 2016-11-09 US US15/347,308 patent/US20170209495A1/en not_active Abandoned
-
2020
- 2020-06-22 US US16/908,037 patent/US20210145892A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2406393A1 (en) | 2001-10-25 |
JP2003531125A (ja) | 2003-10-21 |
HK1052645A1 (en) | 2003-09-26 |
ES2288946T3 (es) | 2008-02-01 |
EP1272204B1 (en) | 2007-06-20 |
US9499791B2 (en) | 2016-11-22 |
CY1108090T1 (el) | 2014-02-12 |
EP1272204A2 (en) | 2003-01-08 |
US20160303169A9 (en) | 2016-10-20 |
WO2001078754A2 (en) | 2001-10-25 |
US20090098094A1 (en) | 2009-04-16 |
JP5684963B2 (ja) | 2015-03-18 |
DE60129007T2 (de) | 2008-02-28 |
CA2406393C (en) | 2012-10-02 |
WO2001078754A3 (en) | 2002-04-25 |
PT1272204E (pt) | 2007-10-02 |
US20170209495A1 (en) | 2017-07-27 |
AU2001251599B2 (en) | 2006-03-02 |
US20210145892A1 (en) | 2021-05-20 |
DK1272204T3 (da) | 2007-09-10 |
DE60129007D1 (de) | 2007-08-02 |
AU5159901A (en) | 2001-10-30 |
ATE365045T1 (de) | 2007-07-15 |
JP2012180355A (ja) | 2012-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5159901A (en) | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof | |
SG146691A1 (en) | Methods of preparing and using stem cell compositions and kits comprising the same | |
EA200600076A1 (ru) | Композиции и способы увеличения активности теломеразы | |
CA2344222A1 (fr) | Mousse proteique adhesive a usage chirurgical et/ou therapeutique | |
AP2000001905A0 (en) | Peptide compositions and formulations and use of same. | |
EP1077254A3 (en) | Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof | |
NO2014010I2 (zh) | ||
IL159895A0 (en) | Methods of generating human cardiac cells and tissues and uses thereof | |
MXPA04001334A (es) | Materiales y metodos para promover la reparacion de tejido nervioso. | |
NO20033177L (no) | Injiserbare depotpreparater og deres anvendelse | |
WO2005038012A3 (en) | Cartilage and bone repair and regeneration using postpartum-derived cells | |
WO2005011569A3 (en) | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer | |
WO2005061019A3 (en) | Methods and composition for soft tissue feature reconstruction | |
WO2008066886A3 (en) | Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same | |
WO2001038303A3 (fr) | Analogues de la vitamine d | |
WO2002007749A3 (en) | Device providing regulated growth factor delivery for the regeneration of peripheral nerves | |
WO2004039832A3 (en) | Leptin-related peptides | |
WO2001094541A3 (en) | Human mesenchymal progenitor cell | |
AU2002366433A1 (en) | Methods and compositions for treating metabolic bone diseases relating to human endokine alpha | |
MXPA05003818A (es) | Perfilamiento de la expresion genica de muestras ffpe. | |
WO2001094586A3 (en) | Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof | |
GB2454154A (en) | Aglet for attachment to a graft material | |
WO2003029432A3 (en) | Human mesenchymal progenitor cell | |
WO2002062301A3 (en) | Method and composition for rejuvinating cells, tissues, organs, hair and nails | |
EP2179738A3 (en) | Use of mesenchymal stem cells for treating osteoporosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20210411 |